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Ectopic Expression of Syndecan-1 in Basal Epidermis
Affects Keratinocyte Proliferation and Wound
Re-Epithelialization
Nkemcho Ojeh1, Katri Hiilesvuo2, Anni Wa¨rri2, Markku Salmivirta2,{, Tiina Henttinen2 and Arto Ma¨a¨tta¨1
Epidermal proliferation and differentiation can be regulated by soluble morphogens and growth factors.
Heparan sulfate proteoglycans (HSPGs) modulate the action of several of these effector molecules, such as
members of the fibroblast growth factor (FGF) and Wnt families. Syndecan-1 is a cell-surface proteoglycan that
is expressed in differentiating keratinocytes and transiently upregulated in all layers of the epidermis upon
tissue injury. To address the role of syndecan-1 in the regulation of keratinocyte proliferation and
differentiation, we generated transgenic mice that overexpress syndecan-1 under K14 keratin promoter in the
basal layer of the epidermis. We observed epidermal hyperproliferation in newborn transgenic mice, as
evidenced by increased number of suprabasal cell layers, elevated proliferating cell nuclear antigen (PCNA)
expression in both basal and suprabasal cell layers and by expression of keratin 6 in the interfollicular
epidermis. Compared to both wild-type and syndecan-1-null animals, the transgene expression interfered with
skin wound healing in adult mice by decreasing cell proliferation in the re-epithelialized epidermis. Thus,
syndecan-1 regulates keratinocyte proliferation differently during skin development and in healing wounds.
Journal of Investigative Dermatology (2008) 128, 26–34; doi:10.1038/sj.jid.5700967; published online 12 July 2007
INTRODUCTION
Epidermal differentiation is a tightly controlled process that
maintains the assembly of the epidermal barrier against the
outside environment. The shed, terminally differentiated
keratinocytes are replenished by a sequential action of two
functionally distinct cell populations in the basal layer of the
epidermis. The epidermal stem cells exist as clusters of
infrequently dividing cells that give rise to transit amplifying
daughter cells. The transit amplifying cell population
comprises the majority of cells undergoing division at any
given time in the epidermis. The progeny of the transit
amplifying cells eventually withdraws from the cell cycle and
undergoes remarkable morphological and biochemical
changes, leading to the formation of anuclear and flattened
cell envelopes (reviewed in Niemann and Watt, 2002;
Blanpain and Fuchs, 2006; Watt et al., 2006).
The regulation of epidermal differentiation involves
several interlinked signaling pathways. These include the
Wnt/b-catenin/T-cell factor pathway in the determination of
epidermal cell lineage commitment (Gat et al., 1998;
Niemann et al., 2002) and Sonic hedgehog that is implicated
in hair follicle development together with Wnt signaling
(St-Jacques et al., 1998; Silva-Vargas et al., 2005).
Another inherent feature of epidermal cells is an ability to
respond rapidly to epidermal injury by a burst of cell
proliferation and migration to regenerate the epidermis.
Epidermal wound healing involves presentation of and
signaling by growth factors and cytokines secreted by
infiltrated immune cells, dermal fibroblasts, and activated
keratinocytes (Werner and Grose, 2003). For example,
signaling via fibroblast growth factor receptor 2-IIIb appears
to be required for efficient wound healing, indicating a role
for fibroblast growth factor (FGF), family members FGF-7,
FGF-10, and FGF-22 in the induction of proliferation and
migration of epidermal keratinocytes (Werner et al., 1994;
Xia et al., 1999; Beyer et al., 2003).
Heparan sulfate proteoglycans (HSPGs) modulate the fate
of several signaling molecules implicated in epidermal
homeostasis and repair. These growth factors and cytokines
include members of the FGF (Rapraeger et al., 1991;
Guimond et al., 1993; Loo and Salmivirta, 2002), Wnt
(Tsuda et al., 1999; Alexander et al., 2000; Baeg et al., 2001),
transforming growth factor b/bone morphogenetic protein
(Lyon et al., 1997; Rider, 2006) families, as well as Sonic
hedgehog (The et al., 1999; Rubin et al., 2002) and heparin-
binding epidermal growth factor-like protein (Aviezer and
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Yayon, 1994). The interactions between oligosaccharide
sequences in the glycosaminoglycan (GAG) side chains of
HSPGs and growth factors can sequester the growth factors in
the extracellular matrix, protect the growth factors against
proteolysis, or act as a necessary component of the signaling
complex (Gallagher, 2001; Nakata and Kimata, 2002).
Syndecans are cell-surface HSPGs that contain an
ectodomain decorated with up to four long GAG chains, a
transmembrane domain and a short, conserved cytoplasmic
domain, that interacts with adapter proteins such as syntenins
and calmodulin-associated serine/threonine kinase (CASK).
Moreover, the cytoplasmic tail of at least syndecans 2 and 4
can bind directly to signaling proteins such as protein kinase
C (see Bass and Humphries, 2002; Fears and Woods, 2006 for
recent reviews). Syndecan-1 harbors both heparan and
chondroitin sulfate side chains and is the most abundant
family member in the epidermis. Syndecan-1 is strongly
expressed in the suprabasal, differentiating epidermal cells,
and only present in low levels in the basal cells comprising
the proliferating cell populations (Sanderson et al., 1992; Inki
et al., 1994b). However, the expression level of syndecan-1
in all cell layers of the epidermis is markedly upregulated
upon wounding (Elenius et al., 1991). A role for syndecan-1
in the regulation of wound healing is underlined by
investigation of corneal wound healing in syndecan-null
mice (Stepp et al., 2002). The wounded syndecan-negative
corneas failed to initiate a proliferative burst 24 hours after
wounding. In addition, the migration of the corneal cells was
hampered by the absence of syndecan-1 (Stepp et al., 2002).
To study the function of HSPGs in the regulation of
epidermal differentiation and wound healing, we utilized
human keratin 14 promoter to express human syndecan-1 in
mouse epidermis. We report here that syndecan-1 over-
expression can increase proliferation of newborn epidermal
keratinocytes and change the expression of differentiation-
related proteins. However, the transgene expression
compromises normal epidermal regeneration during adult
wound healing by reducing cell proliferation of the newly
re-epithelialized epidermis.
RESULTS
Generation of syndecan-1 transgenic mice
Syndecan-1 is the predominant cell-surface proteoglycan in
the epidermis, where it is localized mostly to the surface of
suprabasal spinous cells (Sanderson et al., 1992; Inki et al.,
1994b). We confirmed that these observations are also valid
in newborn mouse epidermis. Immunostaining of mouse
syndecan-1 in the epidermis of newborn mice revealed very
low expression in the basal epidermis compared to supraba-
sal cells (Figure 1a). Furthermore, we established that in the
inbred C57 Bl/6J strain used in our studies, syndecan-1
expression is strongly upregulated throughout the hyperpro-
liferative wound edge epidermis (Figure 1b). To investigate
the biological role of restricted expression of syndecan-1 in
the stem and transit amplifying (TA) cell compartments of the
epidermis, we used a construct where the coding region of
the human syndecan-1 gene is under the human K14 keratin
promoter (Figure 1c) to generate transgenic mice. Six DNA-
positive founder animals were detected and subsequently
shown to transmit the transgene to the next generation. Two
lines with equally high expression levels of the transgene
were maintained for further studies.
The expression of human syndecan-1 in transgenic skin
was confirmed by Northern blotting and immunohistochemi-
cal staining, using the mAb B.B4 specific for human
syndecan-1 (Wijdenes et al., 1996). In the skin, strong
specific staining was observed only in the basal layer of the
epidermis of DNA-positive animals (Figure 1d) in all
analyzed founder lines, indicating that the transgene was
correctly expressed in the epidermal stem cells and basal
transit amplifying keratinocytes only. No specific staining
was observed in the skin of negative littermates (Figure 1e).
Likewise, expression of human syndecan-1 was detected in
total skin RNA of transgenic but not control littermate mice
(Figure 1f). As the transgene expression was confined to the
K14 promoter
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Figure 1. Generation of K14-HSyn transgenic mice. (a) Endogenous mouse
syndecan is expressed most strongly in the spinous and granular cell layers of
the epidermis. Mouse epidermis was stained with the rat mAb 281-2 against
syndecan-1 core protein. The arrowhead in panels a, b, and d points at the
dermal–epidermal junction. (b) Upon wounding, syndecan-1 expression is
upregulated in the proliferating keratinocytes, but downregulated at the
leading front of migrating epidermal sheet (*). (c) The transgenic construct.
Gray rectangles represent the promoter and 30untranslated region of the
human K14 keratin gene. The white rectangle represents the coding region of
the human syndecan-1 full-length cDNA. K, KpnI; S, SacII; E, EcoRV; the
EcoRV sites indicate the diagnostic fragment used in Southern blots.
(d) Immunohistochemical detection of the transgene expression in the tail
epidermis of a DNA-positive mouse. Human syndecan-1 was detected with
mAb B.B4. (e) B.B4 staining of the skin of a control littermate. No specific
staining can be detected. The arrowhead in panels d and e indicates the basal
cell layer. (f) Detection of the transgene mRNA in the epidermis by Northern
blotting. Human syndecan 1 mRNA (right hand panel) was present in the total
RNA isolated from the skin of DNA-positive mice (Tg, middle lane), but
absent in the skin of DNA-negative littermates (WT, outer lanes). Endogenous
mouse syndecan-1 mRNA was present in all skin samples (left hand panel).
Bar, 50mm.
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basal layer and the majority of endogenous syndecan-1 was
present in the suprabasal epidermis, the cells expressing the
transgene showed at least five-fold overexpression of the
protein, compared to the endogenous gene.
Transgenic syndecan is a heparan and chondroitin sulfate
proteoglycan
To verify whether the human syndecan detected in the basal
epidermis of the transgenic animals is expressed as a
proteoglycan, we purified diethylaminoethyl (DEAE)-bound
proteoglycan fractions from the skin of transgenic mice and
control littermates. Endogenous mouse syndecan-1 (from the
suprabasal keratinocytes) was further separated from the total
proteoglycan fraction by affinity to mAb 281-2 sepharose
beads. Proteoglycan fractions from 281-2-bound and un-
bound material were subjected to gradient gel electrophoresis
and detected by Western blotting (Figure 2a). Both the
endogenous and transgenic syndecans run as a smear from 90
to 200 kDa, as expected, from proteoglycans carrying GAG
side chains of heterogeneous size (Figure 2a). Endogenous
syndecan was of equal size and approximately equally
abundant in the epidermis of both DNA-positive and
-negative mice. The mAb B.B4 detected proteoglycans only
in the skin samples from the DNA-positive animals (Figure
2a). Furthermore, B.B4-reactive proteoglycans were only
present in the fraction that was not bound to 281-2 sepharose
beads (Figure 2a), which confirms that B.B4 does not cross-
react with the endogenous mouse syndecan. The digestion of
the proteoglycans by heparitinase or chondroitinase revealed
that most side chains attached to the transgenic human
syndecan core protein were relatively long heparan sulfate
chains (Figure 2b). The digestion of the total proteoglycans
fraction with heparitinase reduced the proteoglycans smear to
a fuzzy band of about 90 kDa, whereas chondroitinase ABC
digestion affected the size distribution of the proteoglycans
only slightly, but reduced the intensity of the smear (Figure
2b). These results are consistent with the previous descrip-
tions of syndecan-1 structure in cultured human keratinocytes
(Sanderson et al., 1992).
Epidermal hyperproliferation in the K14-HSyn transgenic mice
Histological analysis of skin from newborn F1 generation
transgenic K14-HSyn mice revealed large areas of thickened
epidermis (Figure 3). The transgenic epidermis appeared to
have a normal cornified layer, occasional parakeratosis in the
granular layer, and increased number of spinous cell layers
(Figure 3b). The number of suprabasal cell layers was
increased and flattening and anucleation of the cells
appeared to be delayed (Figure 3). The extent of the
hyperproliferation appeared to vary between different skin
locations and between individual mice. Some lesions
contained localized areas of remarkably thickened epidermis
that appeared to involve some downgrowth into the dermis
(Figure 3c).
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Figure 2. Transgenic syndecan-1 is expressed as a proteoglycan with
attached heparan and chondroitin sulfate chains. (a) Western blot of
proteoglycans purified from the skin of transgenic and control mice. Total
proteoglycans from transgenic (tg) and control mouse (wt) skin were further
fractioned by mAb 281-2 affinity beads to bound (b; endogenous mouse
syndecan) and unbound supernatant (s; all other proteoglycans) fractions,
separated on a gradient SDS-PAGE and blotted with either mAb 281-2 or B.B4
against human syndecan-1. Note that B.B4 recognizes a proteoglycan only in
the TG skin, and does not cross-react with the endogenous, 281-2-bound
syndecan-1. Lines indicate migration of 200 and 70 kDa molecular weight
markers. (b) Transgenic syndecan-1 harbors heparan sulfate and chondroitin
sulfate side chains. Purified proteoglycans from the skin of a transgenic mouse
were incubated with the digestion buffer alone (control) or digested with
heparitinase (H’ase) or chondroitinase ABC (C’ase) before separation in a
2–15% gradient SDS-PAGE and Western blotting with B.B4 mAb against
human syndecan-1.
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Figure 3. Hyperproliferation in newborn K14 Hsyn epidermis.
(a) Hematoxylin–eosin-stained back skin section from 3 day-old-control
mouse mice. (b) Hematoxylin–eosin stained back skin section K14 Hsyn
transgenic, (c). K14 Hsyn transgenic (different founder line than in panel b).
(d) PCNA staining of a control back skin section. (e) Quantitation of
PCNA-positive nuclei. Percentages of PCNA-positive nuclei in basal and first
suprabasal cell layers of control and transgenic mice (three each) were
counted from digital microscope images. Error bars indicate standard
deviation. The difference in the PCNA-positive nuclei was statistically
significant (t-test, Po0.05). (f) PCNA staining of K14 Hsyn transgenic back
skin section. Bar, 50 mm.
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To analyze whether the thickened epidermis resulted from
increased proliferation, we stained paraffin sections of
transgenic and wild-type epidermis with an antibody against
proliferating cell nuclear antigen (PCNA). The number of
proliferating cells was significantly increased in the epidermis
of transgenic mice and PCNA-positive cells were frequently
seen in the first suprabasal cell layer, while less than 1% of
the suprabasal cells were PCNA positive in the control
epidermis (Figure 3d–f). A similar increase in proliferating
cells was also seen by immunostaining the newborn mouse
interfollicular epidermis with an antibody against Ki67
proliferation marker (Figure S1). Interestingly, no change in
Ki67 immunoreactivity was observed in hair follicle outer
root sheaths or hair bulbs (Figure S1). No difference was
observed in the expression or distribution of two syndecan-
binding growth factors, FGF-2 and FGF-7, indicating that the
altered keratinocyte proliferation is not due to increased
expression of these growth factors. FGF-2 expression was
detected predominantly in basal keratinocytes, whereas FGF-
7 was expressed at low levels in the dermis (Figure S2). These
data are consistent with previous reports on the tissue
distribution of these growths factors (Schulze-Osthoff et al.,
1990; Werner et al., 1992; Kibe et al., 2000).
Expression of epidermal differentiation markers in K14-HSyn
transgenic mice
Epidermal hyperproliferation, wound healing, and other
epidermal cellular stress situations are usually accompanied
by expression of K6 keratin (Fuchs, 1995). In the control
animals, K6 was restricted to the hair follicles (Figure 4a),
whereas in the hyperproliferative transgenic epidermis, strong
K6 expression was seen in both hair follicle outer root sheath
and the interfollicular epidermis (Figure 4b). During epider-
mal differentiation, expression of K10 replaces K14 in the
suprabasal epidermis. Keratin 10 was expressed in the
transgenic skin in a manner similar to control skin, beginning
mostly in the first suprabasal cell layer (Figure 4c and d).
The progress of terminal differentiation was further
evaluated by studying the expression of involucrin, an early
precursor protein for cornified envelopes (Kalinin et al.,
2002), in the transgenic and control epidermis. Involucrin
expression commenced in the spinous layer and the antibody
staining was strongest in the granular layer (Figure 4e). In the
transgenic epidermis, strong involucrin staining was detected
in the upper spinous and granular layers (Figure 4f), thus
indicating that terminal differentiation takes place in the
hyperproliferative transgenic epidermis. We used immuno-
blotting of epidermal cell protein extracts to further evaluate
terminal differentiation of the transgenic keratinocytes
(Figure 5). We also included in our analysis syndecan-1-null
animals that have not been reported to display any phenotype
in uninjured adult epidermis (Stepp et al., 2002). We found
that involucrin expression was not changed in the transgenic
epidermis, and blotting with an antibody against pro-filaggrin
revealed the characteristic ladder of pro-filaggrin processing
in both control and transgenic epidermis (Figure 5). The only
observed sign of a delayed differentiation was relative
absence of crosslinked loricrin in the transgenic epidermis.
Transglutaminase crosslinking of loricrin in the epidermis
resulted in distinct bands in control epidermis, whereas in
transgenic epidermis, the majority of loricin was present as a
single monomeric 30 kDa polypeptide (Figure 5). The sizes of
crosslinked and monomeric loricrin species corresponded
well to those observed in in vitro crosslinking assays (Candi
et al., 2001). In contrast to K14 hSyn transgenic mice, no
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Figure 4. Keratin and involucrin expression in the K14 HSYn transgenic
epidermis. (a) Keratin 6 expression in control skin. Note that the staining is
restricted to hair follicles. (b) Keratin 10 staining in the control epidermis.
(c) Keratin 6 staining in the transgenic epidermis. Note the prominent staining
of the interfollicular epidermis. (d) Keratin 10 staining in the transgenic
epidermis. (e) Involucrin expression in control newborn mouse skin.
(f) Involucrin expression in K14Hsyn transgenic mouse skin. Bar equals 50 mm
in all panels.
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Figure 5. Expression of differentiation markers in epidermal protein
extracts. Neonate wild-type (WT), transgenic (Tg) and syndecan-null (KO)
epidermises (three mice each) were isolated by dispase treatment, solubilized
in Laemmli’s buffer, and analyzed by Western Blotting. The blots were probed
with antibodies against pro-filaggrin (top panels), loricrin (middle panels), and
involucrin (bottom panels). The ladder of bands in the filaggrin blot shows
characteristic pattern of pro-filaggrin processing. M indicates monomeric
loricrin and C indicates crosslinked loricrin bands.
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difference between syndecan-1 knock-out animals and wild-
type animals was observed (Figure 5). The delay in loricrin
processing did not affect the completion of the terminal
differentiation program. Furthermore, an in situ assay for
transglutaminases indicated that the combined activities
of transglutaminases 1 and 3 were present in the upper
spinous and granular layers of the transgenic epidermis
(Figure S3).
K14-Hsyn expression interferes with wound re-epithelialization
Endogenous syndecan-1 is up-regulated over 15-fold in the
proliferating and migrating keratinocytes at the wound edge
(Elenius et al., 1991; Figure 1). Recently, Stepp and co-
workers reported that lack of syndecan-1 inhibits keratinocyte
migration and proliferation in corneal wounds (Stepp et al.,
2002). To compare wound healing in K14 Hsyn mice and
syndecan-1-null mice, we bred both genotypes in C57Bl/6J
background for seven generations and performed punch
biopsy wound healing experiment on 6- to 7-week old
(telogen stage hair cycle) animals. At day 3 post-wounding,
when control animals show extensive hyperproliferation at
the wound edge and the knockout mice only slightly less
pronounced activation, there was only a small increase in
epidermal thickness at the K14 hSyn transgenic wound edge
(Figure 6). The difference in keratinocyte proliferation was
even more pronounced at day 7, when the control epidermis
in the middle of the closed wound was stratified and
hyperproliferative (Figure 6d and g), whereas the transgenic
epidermis, although covering the wound, consisted of only a
few layers of flattened keratinocytes that resembled cells
normally seen in the upper spinous and granular layers of the
epidermis (Figure 6e and h). It appeared that only prolifera-
tion, but not keratinocyte migration was affected, as no
difference in wound closure was observed.
The morphology of the syndecan-1-null wounds appeared
to be more variable, but the re-epithelialized epidermis was
usually less well organized and thinner than in controls
(Figure 6f and i). In both transgenic and knockout wounds
(day 7 time point), the granulation tissue appeared to be less
well organized than in control wounds, indicating a possible
role for syndecan-1 in the mediation of signals to either
organize or remodel the newly laid dermis. The difference
between syndecan-1 overexpressing epidermis and control or
syndecan-1-null epidermis was confirmed by morphometric
analysis. Measurements of the thickness of the re-epithelia-
lized epidermis from three independent wounds for each
genotype showed that the transgenic epidermis was signifi-
cantly thinner than either wild type or syndecan knockout
epidermis (measured as the area of epidermis in the middle of
the wound from hematoxylin-eosin stained sections) (Figure
7a). Furthermore, cell proliferation, as visualized by Ki67-
positive nuclei, was greatly reduced in the transgenic
epidermis covering the wound (Figure 7b), compared to re-
epithelialized wild-type wound (Figure 7c).
Isolation of primary keratinocytes from transgenic and
wild-type mice demonstrated that the decreased proliferation
can also be observed in vitro. Transgenic keratinocytes grown
on collagen-coated matrices proliferated very slowly com-
pared to wild-type keratinocytes, and it proved impossible to
establish long-term cultures from these mice (Figure S4).
DISCUSSION
In order to study the role of HSPGs in the proliferation and
differentiation of epidermal keratinocytes, we expressed
human syndecan-1 in the basal layer of mouse epidermis
that harbors epidermal stem cells and their rapidly proliferat-
ing progeny, transit amplifying cells. The transgene expres-
sion was restricted to the basal layer of the epidermis and the
outer root sheath of hair follicles, as shown by immuno-
histochemical staining (Figure 1). Importantly, the transgene
was expressed as a proteoglycan that, as expected for
syndecan-1, carried both heparan sulfate and chondroitin
sulfate side chains (Figure 2). This confirms the functionality
of the transgene-derived protein as a proteoglycan. Neither
the mRNA levels nor the GAG composition of the endo-
genous mouse syndecan-1 was affected, indicating that the
transgene expression did not compromise expression of other
proteoglycans.
a b
c d
e
g h i
f
Figure 6. Wound healing in K14 Syn and syndecan/ mice.
(a–c) Hematoxylin–eosin staining of punch biopsy wound 3 days
after wounding. Arrowheads indicate hyperproliferative epidermis at wound
edge, and *indicates the migrating epidermal front. (a) Wild type,
(b) K14-hSyn transgenic, (c) syndecan-1 null. (d–f) Hematoxylin–eosin
stainings of 7-day-old punch biopsy wounds. Arrows indicate the wound
edges. (d) Wild type, and (e) K14Hsyn transgenic mice. Note the thin
re-epithelialized epidermis, (f) syndecan-1-null mouse.
(g–i) High-magnification images of the new epidermis. (d) Wild type,
(e) K14Hsyn transgenic, (f) syndecan-1 null mice. Bar in panels a–f equals
200mm, and in panels g–i equals 50mm.
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Newborn transgenic mice exhibited hyperproliferative
skin lesions that were characterized by suprabasal cell
proliferation and increased number of suprabasal cell layers.
The thickened transgenic epidermis expressed keratin 6, a
hallmark of hyperproliferation, but the expression of markers
for terminal differentiation, keratin 10 and involucrin, was
not overtly disrupted. Thus, expression of syndecan-1 in basal
keratinocytes can cause hyperproliferation, but does not
prevent the commitment of the transit amplifying cells to
differentiation. No difference was observed in involucrin
expression levels or in pro-filaggrin processing. Only mono-
meric but not crosslinked loricrin was detected in the
epidermal extracts of transgenic mice, which suggests a
delay in epidermal differentiation (Figure 5). However, it
should be noted that even though loricrin is a major
component of cornified envelopes, it is not essential for skin
homeostasis as loricrin-null mice eventually develop a
normal skin and do not suffer from barrier defects (Koch
et al., 2000).
During wound healing, syndecan-1 is upregulated in the
wound edge keratinocytes (Elenius et al., 1991). The
upregulation is, at least in part, achieved by activation of a
far upstream enhancer element in syndecan-1 gene that in
cultured keratinocytes is responsive to FGF and epidermal
growth factor families of growth factors and is modulated by
interactions with the extracellular matrix (Jaakkola et al.,
1998a, b; Ma¨a¨tta¨ et al., 1999). We found that overexpression
of syndecan-1 has a profound effect on cell proliferation in
the newly re-epithelialized epidermis. This effect is clearly
distinct from the phenotype of the newborn epidermis and
suggests that the ‘‘activated’’ keratinocyte phenotype respon-
sible for re-epithelialization is regulated differently from the
multilayered newborn mouse epidermis.
The difference between the effect of ectopic syndecan-1
expression on epidermal differentiation in newborn mice
compared to adult resting skin and to wound healing is
intriguing. A possible explanation is the role of a large
number of heparin-binding growth factors and cytokines that
are involved in wound healing, although they only play a
small role in normal epidermal homeostasis (reviewed by
Werner and Grose, 2003). Moreover, it is likely that a
different set of growth factors is involved in the development
of the skin, compared to repair of the epidermis in wound
healing. For example, the expression of FGF-7 (keratinocyte
growth factor) that binds to FGFR2IIIb receptor is upregulated
over 100-fold upon wounding (Werner et al., 1992) and
dominant-negative FGFRIIIb impairs wound healing (Werner
et al., 1994). Subsequent biochemical analysis has revealed
that both FGF-7 and the receptor bind heparan sulfate
(LaRochelle et al., 1999). Crucially, at high concentrations,
heparin inhibits FGF-7 but not FGF-1 activity (LaRochelle
et al., 1999). Moreover, only a small fraction of heparin
shows high affinity to FGF-7, as opposed to FGF-1 and FGF-2,
and specifically supports FGF7-FGFRIIIb signaling (Luo et al.,
2006). Thus, overexpression of syndecan-1 can change the
effect of heparan sulfate from promotion to inhibition of FGF-
7 signaling. Likewise, some signaling pathways that are
crucial in skin development, such as wnt/b-catenin pathway,
are not active in the maintenance of the adult epidermal
homeostasis (Posthaus et al., 2002).
Further evidence for the function of syndecan-1 in
keratinocyte proliferation has been obtained from synde-
can-1 knockout mice (Stepp et al., 2002) and from mice that
overexpress syndecan-1 systemically under the cytomega-
lovirus (CMV) promoter (Elenius et al., 2004). Stepp et al.
(2002) analyzed the proliferation of corneal keratinocytes
before and after corneal debridement in syndecan-1 gene
targeted mice. They found that syndecan-1 is required for
induced proliferation and migration of corneal keratinocytes.
The fact that both loss (Stepp et al., 2002) and overexpression
(this study) of syndecan-1 can compromise inducible
keratinocyte proliferation is consistent with the dual effect
of heparan sulfate on and FGF-7 signaling and suggests that
there exists an optimal proteoglycan expression level that
regulates the proliferative potential of keratinocytes during
wound healing.
Elenius et al. (2004) studied wound healing in mice that
overexpress syndecan-1 in several tissues, including the skin
and blood. The elevated levels of shed syndecan-1 ecto-
domain in these animals inhibit both re-epithelialization and
remodeling of the newly laid matrix in dermis. Since the
wound healing of wild-type skin grafted to overexpressing
mice was also hampered, the effects were largely attributed to
the systemic overexpression affecting also the dermis, blood
vessels, and immune cells (Elenius et al., 2004). In this study,
we have been able to pinpoint the keratinocyte-specific
effects of syndecan-1 expression by using a transgene only
expressed in basal keratinocytes. Notably, the studies
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Figure 7. Epidermal thickness and cell proliferation in re-epithelialized
epidermis. (a) Morphometric measurement of the new epidermis. Mean and
SEM of the transverse area of epidermis in the middle of the wound of
hematoxylin–eosin stained paraffin sections from three independent wounds
for each genotype. The difference between wild-type mice and transgenic
mice is statistically significant (t-test, Po0.05). (b) K14 Hsyn transgenic
mouse, Ki67 immunohistochemistry. Note the lack of cell proliferation in the
epidermis covering the wound (arrow). (c) Wild type, Ki67
immunohistochemistry. Note cell proliferation in the epidermis covering the
wound (arrow). Ki67-positive sebaceous gland nuclei are indicated with * in
panels b and c. Bar equals 50 mm in panels b and c.
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conducted by us and by Elenius et al. (2004) indicate that
syndecan-1 expressed either by keratinocytes themselves or
by the other surrounding cell types can equally modify
keratinocyte proliferation. Our studies also support the
observations of Elenius et al. (2004) that organization of
granulation tissue is influenced by syndecan-1 expression in
skin. The changes in the granulation tissues seen in both
studies and the increase of dermal cell proliferation observed
in the newborn transgenic skin suggests that epidermal
expression of syndecan-1 can influence signaling in dermal
cells.
In conclusion, syndecan-1 is an important modulator of
epidermal cell proliferation. Stepp et al. (2002) recently
reported how syndecan-1 knockout mice display impaired
proliferation and migration of corneal keratinocytes in eye
abrasion wound healing. Here, we have demonstrated that
overexpression of syndecan-1 in basal keratinocytes pro-
motes keratinocyte proliferation during epidermal develop-
ment, but restricts proliferation during wound healing. Taken
together, these studies suggest a role for syndecan-1 in the
control of the proliferative potential of epidermal transit
amplifying cells.
MATERIALS AND METHODS
Generation of transgenic mice and animal procedures
To target the expression of human syndecan-1 in the basal layer of
the epidermis in mice, we subcloned the coding region of full-length
human syndecan-1 cDNA (Mali et al., 1990) into an expression
vector containing human keratin K14 promoter and 30untranslated
region (Vassar et al., 1989). The K14hSyn insert was purified for
microinjection and founder mice were generated using standard
transgenic methods. DNA-positive mice were identified by Southern
blotting of tail-tip DNA. For Southern blotting, the genomic DNA
was cut with EcoRV, electrophoresed, and transferred on Hybond
Nþ (GE Healthcare, Little Chalfont, Buckinghamshire, UK) filters
and probed with full-length syndecan-1 cDNA or an EcoRV fragment
(Figure 1c) encompassing part of the K14 promoter and part of the
human syndecan-1 cDNA. K14Hsyn overexpressing mice and
syndecan-1-null mice (Stepp et al., 2002) were bred to C57Bl/6J
background for seven generations, to minimize any effect of
variation of the genetic background in subsequent experiments.
Animal work was approved by Animal Ethics Committees of
Universities of Turku and Durham and covered by a UK Home
Office Project license.
To study wound healing in overexpressing, gene targeted
syndecan-1-null and C57Bl/6J wild-type control mice, 6 to 7-week
old animals were shaved; 2 days later, only animals that were still in
the resting phase of the hair follicle cycle were used in the
experiments. Punch biopsy wounds measuring 3 mm were made on
the back skin of anesthetized mice. At days 3, 5, 7, and 10 post-
wounding, the animals were killed and wound tissue along with
some surrounding skin was excised and processed for histology and
immunohistochemistry.
Primary keratinocytes were isolated and grown in Defined
Keratinocyte Growth Medium (Invitrogen, Paisley, UK) on col-
lagen-coated culture dishes, as described earlier (Ma¨a¨tta¨ et al.,
2001). Cell proliferation was measured as the number of viable cells,
as described (Long et al., 2006).
RNA isolation and Northern blotting
Total RNA was isolated from snap–frozen skin samples by homo-
genization in 4 M guanidinium isothiocyanate and subsequent
ultracentrifugation, as described (Mali et al., 1990). A 10 mg weight
of total RNA was separated on a 1% agarose gel, in the presence of
formaldehyde, transferred on Hybond-N membranes, and sequen-
tially probed with human and mouse syndecan-1 cDNA probes.
Purification of proteoglycans
Whole trunk skins of 1-week-old transgenic mice and their DNA-
negative control littermates were snap–frozen in liquid nitrogen. The
skins were homogenized in phosphate-buffered saline containing
1 mM phenyl-methane-sulfonyl-fluoride (PMSF), 1% Nonidet P40,
0.1% deoxycholate, and 0.1% SDS, sonicated for 5 minutes in a bath
sonicator, and rotated for 15 minutes at þ 41C. Detergent-insoluble
material was separated by centrifugation and proteoglycans were
isolated from the supernatants by DEAE sephacel, as described
previously (Salmivirta et al., 1991). Endogenous mouse syndecan-1
was further affinity purified from the DEAE eluate by mAb 281-2
linked to Sepharose CL-4B beads (Pharmacia). GAG content of
endogenous and transgene derived syndecans was determined by
digestion of the chains using 1 mU/ml heparitinase and/or 0.1 U/ml
chondroitinase ABC (Seikagagu Kogyo, Tokyo, Japan), as described
(Elenius et al., 1990).
Epidermal protein extracts and Western blotting
Isolated murine skin pieces were incubated in 1.2 U/ml dispase
(Roche Molecular Biochemicals, Mannheim, Germany) overnight at
41C. The epidermis was peeled away from the dermis, washed twice
in phosphate-buffered saline (calcium/magnesium free), and snap–-
frozen in liquid nitrogen. Whole cell protein was extracted from the
separated epidermis using 2 Laemmli’s sample buffer supplemen-
ted with protease inhibitor cocktail (Roche, Mannheim, Germany).
Protein concentration was determined using the BCA protein assay
reagent kit (Pierce, Cramlington, UK). Immunoblotting was per-
formed using the semi-dry blotting method, according to the
manufacturer’s instructions (Bio-Rad, Hertfordshire, UK). 12–25mg
proteins were loaded and were separated on 4–12% Bis–Tris gradient
gels (Invitrogen) and transferred onto Hybond nitrocellulose
membranes (Amersham Pharmacia Biotech, Little Chalfont, Buck-
inghamshire, UK). The membranes were probed using a panel of
primary antibodies (filaggrin polyclonal antibody diluted 1:400
(PRB-417P; Covance, Berkeley, CA), Loricrin polyclonal antibody
diluted 1:500 (ab24722; ABCAM, Cambridge, UK), Involucrin
polyclonal antibody diluted 1:1,000 (ab28057; ABCAM) for 1 hour
at room temperature. Protein bands were visualized using the ECL
Plus chemiluminescent detection reagent (Amersham Pharmacia
Biotech) on luminescent image analyzer (LAS-1000plus; Fuji Photo
Film, UK).
Purified proteoglycans (mAb 281-2-bound and unbound frac-
tions) were separated in 2–15% gradient SDS-PAGE gels and blotted
on Hybond Nþ membranes. Human syndecan-1 was detected by
mAb B.B4 (Serotec, Oxford, UK) and mouse syndecan-1 by mAb
281-2.
Histology and immunohistochemistry
Tissue samples were fixed in phosphate-buffered formaline and
embedded in paraffin blocks. Deparaffinized sections (5mm thick)
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were cut and immunohistochemistry was performed using Vectas-
tain ABC kit (Vector Laboratories, Orton Southgate, Peterborough,
UK). The primary antibodies used were as follows: mAb B.B4
(Serotec) for human syndecan-1; rat mAb 281-2 for mouse syndecan-
1; a rabbit polyclonal against mouse involucrin; MK6, rabbit
polyclonal against mouse keratin 6; MK10 rabbit polyclonal against
mouse keratin 10 (all from Covance); NCL-PCNA (Novocastra,
Newcastle Upon Tyne, UK) against PCNA; NCL-L-Ki67-MM1
(Novocastra) against proliferation antigen Ki67; polyclonal anti
bFGF (40–63) (Calbiochem, Merck Chemicals Ltd., Nottingham,
UK); and polyclonal anti FGF-7 (C19) (SantaCruz, Autogen Bioclear
UK Ltd., Wiltshire, UK). Transglutaminase activity was visualized in
unfixed frozen sections by using fluorescently labeled monodansyl-
cadaverine (Invitrogen) as substrate, as described (Raghunath et al.,
1998).
PCNA-positive nuclei were scored from digital micrographs of
stained sections (three sections each from mice from two different
founder lines). Number of positive nuclei was compared by Student’s
t-test.
Epidermal thickness in the re-epithelialized 7-day old wounds
was analyzed by measuring a defined area of the epidermis in pixels
from digital photomicrographs (50 original magnification) by NIH
Image program. An equally wide section from the middle of the
wound of three independent wounds from each genotype was
analyzed.
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